NKCL Bio Group Inc.
announced on the 25th that it had won awards in two categories, the Technology
Innovation Division and the Innovation Division of the Ministry of SMEs and
Startups, at the ‘9th 2022 TV Chosun Management Grand Awards’.
It is an awards
ceremony hosted by TV Chosun and sponsored by a total of 10 sponsors, including
the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy,
the Ministry of Employment and Labor, the Ministry of Health and Welfare, the
Ministry of SMEs and Startups, and the Ministry of Food and Drug Safety. This
award is given to companies, institutions, and individuals who create new
values and present new standards through creative management innovation and
bold challenges in the new normal era such as the 4th industrial revolution and
explained the reason for the selection and said, "NKCL Bio Group has been
highly evaluated for its contribution to corporate social responsibility,
improving corporate management and increasing productivity through the development
of new technologies and the development of technologies in use."
NKCL Bio Group
is a bio-specialized company that researches and develops NK cell treatment, a
next-generation anti-cancer treatment using Natural Killer Cell (NK Cell),
which is in charge of the most important immune system in our body. NKCL Bio
Group was recognized for its excellent technology in the field of cell culture
by the Tech Credit Bureau of NICE Evaluation Information.
NK cells are
natural killer cells that recognize and attack cancer cells and abnormal cells.
NKCL is leading the technology and market in the NK cell field by developing a
GMP automatic culture system that enables mass production of NK cell culture.
NKCL Bio Group
actively responds to the rapidly changing era, attracting attention as a
representative of Korea's immune brand More than 300% of jobs were created
compared to the previous year through the expansion of production facilities
for the GMP automatic culture system in 2022, also more than 1,000% of jobs are
expected to be created in 2023.
NKCL Bio Group is building and operating an immune care platform for 1:1
customized immune cell therapy through the GMP automatic culture system based
on its excellent technology.
Chairman Shin, Donghwa announced that NKCL Bio Group, which launched a flare in
the popularization of NK immune cells, plans to accelerate the NK immune cell
culture business by developing and establishing an automatic culture system
that combines artificial intelligence and cell culture technology. He said, “In
the automatic cell culture system, artificial intelligence can determine the
optimal culture environment for each individual by combining expert data and
know-how with artificial intelligence. In addition, it has the advantage of
being able to fundamentally block concerns about human error and technology
the ‘2022 TV Chosun Management Grand Awards’ ceremony, which celebrated its 9th
this year, Song, Hoseop, CEO of Starbucks Korea (Job Creation Management
Division), and Genesis BBQ Group Chairman Yoon, Honggeun (Global Management
Awards Division) were named. Newly awarded in 2022, Hankuk Paper CEO Ahn, Jaeho
(ESG Management Award) and NKCL Bio Group Chairman Shin, Donghwa (Technical
Innovation, Innovation) were included.
디지틀 조선: https://digitalchosun.dizzo.com/site/data/html_dir/2022/12/13/2022121380099.html